Target intelligence / Profile preview

BMS1P4-AGAP5 readthrough (BMS1P4-AGAP5)

Target: BMS1P4-AGAP5
Molecular classification: Pseudogene, Readthrough transcript

Overview

BMS1P4-AGAP5 is a readthrough pseudogene formed by transcriptional readthrough between the BMS1P4 and AGAP5 loci on chromosome 10. The resulting transcript is a candidate for nonsense-mediated mRNA decay and is highly unlikely to produce any protein product or exert any biological effect. It is not considered a receptor, enzyme, transporter, or any other typical therapeutic target class, and has no documented interacting drugs, mechanisms of therapeutic action, biomarker status, or safety concerns. Its designation occasionally leads to confusion with protein-coding genes, but it is not an actionable or functional molecular target[3].

Other names: BMS1P4-AGAP5 readthroughBMS1P4-AGAP5HGNC: 55636NCBI Gene: 113939925Ensembl: ENSG00000242288Various previous GeneCards identifiers

Mechanism of action

None (As a pseudogene with no known protein product, there is no mechanism of action for drugs)

Biological functions

Not known to have any protein product or biological function due to its likely degradation through nonsense-mediated decay

Disease associations

None specifically documented; no direct disease role since it does not appear to code for a functional protein

Safety considerations

None (No therapeutic use or known safety concerns)

Interacting drugs

None (No drugs are known or predicted to interact with this readthrough/pseudogene)

Biomarkers

None (Not used as a biomarker for patient selection or efficacy monitoring)

Beyond the preview

Go deeper on BMS1P4-AGAP5 readthrough (BMS1P4-AGAP5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BMS1P4-AGAP5 readthrough (BMS1P4-AGAP5).

Explore the full profile